Vepafestinib
Vepafestinib is a small molecule inhibitor targeting the RET kinase, exhibiting promising antineoplastic properties. It is utilized in oncology research to study RET-driven cancers, with applications in both in vitro biochemical assays and in vivo tumor model studies.
Product Specifications
CAS Number
2129515-96-2
Product Name Alternative
CRET, Vepafestinib, RET
Field of Research
Cell Biology, Signal Transduction
Purity
98.54% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.11 mM) ; DMSO:45 mg/mL (94.83 mM)
Smiles
COCc1ccc (NC (=O) c2c (C#CCN3CCOCC3) n (c3ncnc (N) c23) C2 (C) CC2) cc1
Molecular Formula
C26H30N6O3
Molecular Weight
474.55
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7077786 Inquire
Recombinant Euryzygomatomys spinosus Cytochrome b (MT-CYB), partial
Sign In for Pricing
View Details 